Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,873 | -13,480 | -15,707 | -19,624 | -17,956 |
| Depreciation Amortization | 722 | -39 | 190 | 444 | 379 |
| Accounts receivable | -437 | 1,066 | -882 | 357 | 336 |
| Other Working Capital | -592 | 1,037 | -921 | 864 | -53 |
| Other Operating Activity | 11,982 | -2,215 | 3,355 | 904 | 2,185 |
| Operating Cash Flow | $-17,198 | $-13,631 | $-13,965 | $-17,055 | $-15,109 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,358 | -29,885 | -19,405 | -41,385 | -48,719 |
| PPE Investments | -1,461 | -240 | -75 | -231 | -141 |
| Sale Of Investment | 21,450 | 24,150 | 66,658 | 36,315 | 2,500 |
| Investing Cash Flow | $-8,369 | $-5,975 | $47,178 | $-5,301 | $-46,360 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 45,000 |
| Debt Repayment | -8 | N/A | -25,000 | 0 | -34,796 |
| Common Stock Issued | 22,790 | 24,969 | 24 | 442 | 68,587 |
| Other Financing Activity | -796 | -2,490 | -1,125 | -46 | -9,920 |
| Financing Cash Flow | $21,986 | $22,479 | $-26,101 | $396 | $68,871 |
| Beginning Cash Position | 11,998 | 9,125 | 2,013 | 23,973 | 16,571 |
| End Cash Position | 8,417 | 11,998 | 9,125 | 2,013 | 23,973 |
| Net Cash Flow | $-3,581 | $2,873 | $7,112 | $-21,960 | $7,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,198 | -13,631 | -13,965 | -17,055 | -15,109 |
| Capital Expenditure | -1,477 | -250 | -79 | -231 | -151 |
| Free Cash Flow | -18,675 | -13,881 | -14,044 | -17,286 | -15,260 |